118
Views
4
CrossRef citations to date
0
Altmetric
Original Research

A Post Hoc Holter ECG Analysis of Olodaterol and Formoterol in Moderate-to-Very-Severe COPD

ORCID Icon, , , , & ORCID Icon
Pages 1955-1965 | Published online: 10 Aug 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Stefan Andreas, Ulrich Bothner, Alberto de la Hoz, Isabel Kloer, Matthias Trampisch & Peter Alter. (2020) No Influence on Cardiac Arrhythmia or Heart Rate from Long-Term Treatment with Tiotropium/Olodaterol versus Monocomponents by Holter ECG Analysis in Patients with Moderate-to-Very-Severe COPD. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1945-1953.
Read now
Stefan Andreas, Lorcan McGarvey, Ulrich Bothner, Matthias Trampisch, Alberto de la Hoz, Matjaz Fležar, Roland Buhl & Peter Alter. (2020) Absence of Adverse Effects of Tiotropium/Olodaterol Compared with the Monocomponents on Long-Term Heart Rate and Blood Pressure in Patients with Moderate-to-Very-Severe COPD. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1935-1944.
Read now

Articles from other publishers (2)

Cristina Rebordosa, Dóra Körmendiné Farkas, Jukka Montonen, Kristina Laugesen, Florian Voss, Jaume Aguado, Ulrich Bothner, Kenneth J. Rothman, Kristina Zint, Daniel Mines & Vera Ehrenstein. (2022) Cardiovascular events and all‐cause mortality in patients with chronic obstructive pulmonary disease using olodaterol and other long‐acting beta2‐agonists. Pharmacoepidemiology and Drug Safety 31:8, pages 827-839.
Crossref
Jaime A. Rincon, Solanye Guerra-Ojeda, Carlos Carrascosa & Vicente Julian. (2020) An IoT and Fog Computing-Based Monitoring System for Cardiovascular Patients with Automatic ECG Classification Using Deep Neural Networks. Sensors 20:24, pages 7353.
Crossref